1. Home
  2. BIO vs MTZ Comparison

BIO vs MTZ Comparison

Compare BIO & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$352.26

Market Cap

8.0B

Sector

Industrials

ML Signal

N/A

Logo MasTec Inc.

MTZ

MasTec Inc.

HOLD

Current Price

$285.44

Market Cap

21.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
MTZ
Founded
1952
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Water Sewer Pipeline Comm & Power Line Construction
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
21.1B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
BIO
MTZ
Price
$352.26
$285.44
Analyst Decision
Buy
Strong Buy
Analyst Count
4
18
Target Price
$339.75
$339.47
AVG Volume (30 Days)
289.1K
1.5M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
142.61
146.12
EPS
N/A
2.42
Revenue
$2,583,200,000.00
$14,299,171,000.00
Revenue This Year
$2.74
$20.38
Revenue Next Year
$3.20
$10.18
P/E Ratio
N/A
$125.08
Revenue Growth
0.65
16.22
52 Week Low
$236.73
$167.66
52 Week High
$365.00
$441.43

Technical Indicators

Market Signals
Indicator
BIO
MTZ
Relative Strength Index (RSI) 67.48 43.19
Support Level $289.16 $215.15
Resistance Level N/A $310.36
Average True Range (ATR) 11.11 13.49
MACD 0.39 4.53
Stochastic Oscillator 75.11 44.42

Price Performance

Historical Comparison
BIO
MTZ

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.

Share on Social Networks: